+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rosuvastatin"

From
Statins - Global Strategic Business Report - Product Thumbnail Image

Statins - Global Strategic Business Report

  • Report
  • April 2025
  • 192 Pages
  • Global
From
Atherosclerosis Drugs Market Report 2025 - Product Thumbnail Image

Atherosclerosis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Angina Pectoris Drugs Market Report 2025 - Product Thumbnail Image

Angina Pectoris Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
Investigation Report on China's Rosuvastatin Market, 2018-2022 - Product Thumbnail Image

Investigation Report on China's Rosuvastatin Market, 2018-2022

  • Report
  • November 2018
  • 30 Pages
  • China
From
ACE/ARB Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

ACE/ARB Inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
From
From
From
  • 20 Results (Page 1 of 1)
Loading Indicator

Rosuvastatin is a drug used to treat high cholesterol and other lipid disorders. It belongs to a class of drugs known as statins, which work by blocking an enzyme in the liver that is responsible for producing cholesterol. Rosuvastatin is used to reduce the risk of heart attack, stroke, and other cardiovascular events in people with high cholesterol levels. It is also used to reduce the risk of cardiovascular events in people with type 2 diabetes and other risk factors for cardiovascular disease. Rosuvastatin is one of the most widely prescribed statins in the cardiovascular drugs market. It is available in both generic and branded forms, and is often prescribed in combination with other drugs to treat high cholesterol. It is generally well tolerated, with few side effects. The cardiovascular drugs market is a large and growing market, with many different drugs available to treat a variety of conditions. Rosuvastatin is one of the most popular drugs in this market, due to its effectiveness and safety profile. Some companies in the Rosuvastatin market include AstraZeneca, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more